Livongo Health has struck a deal to offer Voluntis’ insulin dose recommendation medical device as part of its diabetes management service.

Integra LifeSciences has made a binding offer to acquire Johnson & Johnson’s Codman Neurosurgery business for about $1.05 billion in cash.

Medtronic has secured FDA clearance to market its OsteoCool RF Ablation System as a palliative treatment for metastatic bone tumors.

GluSense, which is developing a long-term glucose-monitoring implant, has received approximately $1.9 million from the newly launched JDRF T1D Fund.

Medtronic unveiled three new additions to its coronary portfolio to facilitate the treatment of coronary artery disease via the radial artery in the wrist.

University of Michigan scientists have adapted a microscopy technique to accelerate and automate the analysis of brain tissue during tumor removal surgery.

The United Kingdom’s cost watchdog has supported the use of HeartFlow FFRct Analysis to assess patients with stable, recent onset chest pain.

An inspection report obtained by The Wall Street Journal details failings at Theranos' Arizona lab, which include performing tests on incorrectly…

The medical device excise tax cost the industry nearly 29,000, or 7.2%, of its jobs, according to an AdvaMed analysis of Department of Commerce figures.

Medical Devices